Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II

Background. Enzyme replacement therapy (ERT) with iduronate-2-sulfatase recombinant forms (idursulfase and idursulfase beta) is effective for the management of mucopolysaccharidosis type II (MPS II). Patients with Hunter syndrome require lifelong ERT that can negate endogenous enzyme deficiency. How...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia G. Levina (Author), Nato D. Vashakmadze (Author), Leyla S. Namazova-Baranova (Author), Elena A. Vishneva (Author), Mariya S. Karaseva (Author), Natalia V. Zhurkova (Author), Kamilla E. Efendieva (Author), Anna A. Alekseeva (Author), Vera G. Kalugina (Author), Artur V. Zaz'yan (Author)
Format: Book
Published: Union of pediatricians of Russia, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available